Delivery Order SPE2DB22D3301-SPE2DB24FZ1AG
Award Date
7/19/24
Potential Completion Date
7/22/24
Potential Value
$5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $14,937.18, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567215395 ! TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML, a medical commodity used for infectious disease prevention. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of February 11, 2025. Amerisourcebergen Drug Corp is the prime...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML pharmaceutical products. The $2,140.52 order has a completion date of February 27, 2024 and was issued under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 through December 31, 2025. This IDC serves as Amerisourcebergen's primary contract vehicle to deliver...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,379.80 firm fixed price delivery order is for the supply of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML, a vaccine product. The contract has an ultimate completion date of June 9, 2025. Amerisourcebergen Drug Corp is the prime contractor, with no set-aside designation indicated. This award is associated with a larger...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,106.30, is for the delivery of 4567392108 TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML, a pharmaceutical product. The award is a Firm Fixed Price Delivery Order with a completion date of February 27, 2025. This contract is not designated with a set-aside requirement, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,421.00 firm-fixed-price delivery order contract is for the supply of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML, a vaccine product. The contract has a performance period through November 4, 2024 and was awarded on November 1, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The $4,978.56 firm fixed-price contract is for the supply of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML, a pharmaceutical product. The award has an ultimate completion date of August 21, 2024. Amerisourcebergen is a major supplier of pharmaceutical and medical products to the federal government, including various military treatment facilities...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor in the United States. The contract, valued at $8,047.12, is a delivery order for the supply of 4565519680 TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML, a vaccine product. The contract has a firm fixed-price pricing type and an ultimate completion date of August 21, 2024. This award is associated with a larger Indefinite Delivery Contract...
This federal contract award is for the delivery of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,824.62 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 30, 2024. The contract has an ultimate completion date of September 3, 2024 and is not associated with any set-aside program. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC)...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4563635847 TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML pharmaceutical products. The contract has a potential value of $27,368.00 and a completion date of February 13, 2024. This award is part of Amerisourcebergen Drug Corp's broader portfolio of medical supply and pharmaceutical contracts with U.S. government agencies,...
This is a $3,449.50 firm-fixed price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML, a pharmaceutical product, with an ultimate completion date of June 5, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor, and there is no information provided...